We are monitoring the impact of COVID-19 on Oncology Drugs Market Get in touch with us for detailed analysis Know More
Pulished Date September, 2021
ID: 12134
Share on
Share on

Global Oncology Drugs Market Size, Share, Trends, COVID-19 impact & Growth Analysis Report – Segmented By type, drug class, distribution channel, route of administration, drug classification and region – Industry Forecast (2021 to 2026)

Pulished: September, 2021
ID: 12134
Pages: 200

Global Oncology Drugs Market Size (2021 to 2026)

The global oncology drugs market size is predicted to be growing at a CAGR of 9.04% from 2021 to 2026 and worth USD 168.31 billion in 2021 and USD 269.68 billion by 2026.

Oncology helps study, diagnosis, and treatment of cancer. Cancer is a disease where abnormal cells grow uncontrollably and disrupt normal bodily functions. Cancer can be caused to any reasons, some of which include are smoking, viral infections, tobacco use, genetic modifications, bacterial infections, chronic infections, eating habits, and age, etc. Oncology drugs act against both metastatic and benign cancers which may include bone marrow cancer, lung cancer, bone cancer, skin cancer, gastrointestinal cancer, breast cancer, oral cancer, and gynecological cancer, etc. The oncology drugs market includes oral, intravenous, and parental drugs that act upon these abnormal cancerous cells and limit their growth.

MARKET DRIVERS:

The market growth for oncology drugs is driven by the increasing elderly population, well-developed healthcare infrastructure especially in developed economies, higher healthcare expenditures, easy drug approvals, growing interest in the field of pharmaceutical oncology in the R&D sector, and increased prevalence of cancers in both children and adults.

In addition, increasing cancer recurrence rate, increasing healthcare awareness, a strong drug portfolio, and revised FDA regulations are expected to facilitate the oncology drugs market. For example, according to the National Cancer Institute, about 17535,550 new cases of cancer were diagnosed in the US in 2018. According to the World Health Organization in 2018, about 10.3 million deaths worldwide were due to cancer.

Many technological advancements in the field of oncology drugs are expected to drive the market to greater heights during the forecast period. Clinical trials are the backbone that supports and drive the research and development for the growth of the market. The increase in cases of various types of cancers along with the discovery of new types of cancer will drive the demand for oncology drugs, which in turn will improve the market growth rate. According to the World Health Organization (WHO), cancer is an increasing burden and this number of diagnosed cancer cases will increase from 18.7 million in 2018 to 31.5 million in 2040. In addition, various launches and continuous approvals of newer drugs are expected to have a huge impact on the market.

MARKET RESTRAINTS:

Factors such as high costs of oncology drugs, stringent rules and regulations for drug approvals, rising expenses for clinical trials, the growing demand for alternative therapies such as natural remedies and substitutes, and the non-availability of new drugs in developing and rural areas are significant factors which might hamper the growth of the cancer drugs market in the future.

MARKET OPPORTUNITIES:

Currently, many critical patients are in the need of innovation for better oncology drugs. Continuous efforts and innovations are expected for immuno-oncology treatments, and gene and stem-cell therapy agents are under clinical development. Growing competition between key market players has shortened the development phase, and competing therapies are quickly coming into the market. Pharmaceutical companies are developing combination drug therapies for smaller groups of patients, exploring new clinical trials to reduce long-term side effects. This will be essential to ensure that costs are commensurate with the potential patient population. These combination therapies are expected to result in better treatment having a good prognosis rate, which will provide opportunities for upcoming years.

Artificial Intelligence technology allows the analysis of extensive drug and biological data to identify potential drugs with higher success rates and treatment options compared to conventional techniques. This latest technology will help speed up matching cancer patients with needed oncology drugs with the most relevant clinical trials, thereby reducing time and costs.

MARKET CHALLENGES:

Certain side effects of the oncology drugs such as lethargy, immune compression, hypertension, necrosis, etc, and decreased awareness of cancer treatment are expected to challenge the growth of the oncology drugs market. While the unmet need is very high for some areas across the world, due to lack of healthcare infrastructure will limit the market growth rate.

COVID-19 Impact on the global Oncology Drugs Market:

The COVID-19 outbreak has positively impacted the oncology drugs market. Due to the COVID-19 emergency, panic drug purchases have been made by cancer patients amid the lockdown. On the Other hand, pharmaceutical companies had dramatically improved their supply chain management and invested more in their quality control and manufacturing management to recover their losses. The involvement of COVID-19 in the research and development of new therapies has been a significant challenge for the oncology drugs industry.

REPORT COVERAGE:

REPORT METRIC

DETAILS

Market Size Available

2020 to 2026

Base Year

2020

Forecast Period

2021 to 2026

Segments Covered

By Type, Drug Class Type, Distribution Channel, Route of Administration, Drug Classification and Region

Various Analyses Covered

Global, Regional & Country Level Analysis, Segment-Level Analysis, DROC, PESTLE Analysis, Porter’s Five Forces Analysis, Competitive Landscape, Analyst Overview on Investment Opportunities

Regions Covered

North America, Europe, APAC, Latin America, Middle East & Africa

 

This research report on the global oncology drugs market has been segmented and sub-segmented based on type, drug class type, distribution channel, route of administration, drug classification, and region.

Global Oncology Drugs Market - By Type:

  • Lung Cancer
  • Pancreatic Cancer
  • Breast Cancer
  • Prostate Cancer
  • Ovarian Cancer
  • Colorectal Cancer
  • Gastric Cancer
  • Kidney Cancer
  • Brain Cancer
  • Thyroid Cancer
  • Skin Cancer
  • Bladder Cancer
  • Cervical Cancer
  • Blood Cancer
  • Others

Global Oncology Drugs Market - By Drug Class Type:

  • Chemotherapy
  • Targeted Therapy
  • Immunotherapy (Biologic Therapy)
  • Hormonal Therapy

Global Oncology Drugs Market - By Distribution Channel:

  • Hospital Pharmacies
  • Retail Pharmacies/Drug Stores
  • Others

Global Oncology Drugs Market By Route of Administration:

  • Oral
  • Parenteral
  • Others

Global Oncology Drugs Market - By Drug Classification:

  • Branded Drugs
  • Generic Drugs

Global Oncology Drugs Market By Region:

  • North America
  • Europe
  • APAC
  • Latin America
  • Middle East and Africa

Based on the region, North America is expected to experience a good growth rate, growing at a CAGR of 9.6% during the forecast period. This region was the largest regional market, accounting for 33% of the global market in 2020, while APAC was the second largest region, accounting for 30% of the oncology drugs market. North America maintains its dominance in the market due to the increasing prevalence of cancer in the United States. According to the National Cancer Institute, in 2021, approximately 1.9 million people will be diagnosed with cancer in the United States. Recent product launches and harmful eating habits will help expand the market in the region.

Europe is expected to have a remarkable growth rate during the projected period attributed to the high cancer burden in countries like the UK, Germany, and France. In Eastern Europe, the market is expected to post a CAGR of 8.2%. Cancer is very common in European countries. According to Cancer Research UK, in 2017, around 165,000 deaths in the United Kingdom were due to cancer. The market in the UK is expected to increase significantly during the forecast period owing to the growing awareness of the population of cancer.

Other regions that are expected to have the fastest-growing oncology drugs market will be South America and the Middle East, where the growth will be at a CAGR of 12.7% and 10.8% Africa is expected to be the smallest revenue generating regional market during the forecast period, this is due to lack of healthcare awareness where most cancer cases are undiagnosed.

Asia is expected to show a high growth rate of the oncology drugs market in the coming years owing to the rising incidence of cancer cases, the increase in the consumption of tobacco products, and the growth of the aging population in the region. It is expected to experience significant growth due to the increasing population and an increasing number of harmful pollutants. Cancer treatment awareness is driving the growth of the oncology drugs market. India and China are expected to dominate the market due to large populations and higher incidences of cancer in the countries. In addition. According to the National Institute for Cancer Prevention and Research (NICPR), in 2019 in India the total number of cancer deaths was 785,852.

KEY MARKET PLAYERS:

F. Hoffmann-La Roche Ltd, Genentech, Inc., Novartis AG, Pfizer Inc., Bristol-Myers Squibb Company, GlaxoSmithKline plc, Eli Lilly and Company, AstraZeneca, Sanofi, and Bayer AG are some of the notable companies in the global oncology drugs market.

RECENT MARKET DEVELOPMENT:

  • The Johnson and Johnson Company signed an agreement with the tech-based- BenevolentAI, a UK-based start-up company, to mine data to design newer and better oncology drugs.
  • In October 2018, Dr. Reddy's Laboratories Ltd launched their own drug-containing Imatinib Mesylate Tablets in India, a generic version of Novartis which is a best-selling cancer drug, Gleevec, in the US oncology drug market.
  • In April 2019, Sun Pharmaceutical Industries released their drug in the form of INFUGEM injection, which will be used for the treatment of ovarian cancer in the United States.
  • In July 2019, pharmaceutical company Pfizer Inc. initiated into oncology, Pfizer made more profitable innovative drugs including the cancer drug- Vibrance for breast cancer.

1. Introduction                                   

            1.1 Market Definition            

            1.2 Scope of the report                     

            1.3 Study Assumptions                      

            1.4 Base Currency, Base Year and Forecast Periods             

2. Research Methodology                             

            2.1 Analysis Design                

            2.2 Research Phases              

                        2.2.1 Secondary Research     

                        2.2.2 Primary Research          

                        2.2.3 Data Modelling 

                        2.2.4 Expert Validation          

            2.3 Study Timeline                 

3. Report Overview                            

            3.1 Executive Summary                     

            3.2 Key Inferences                 

4. Market Dynamics                           

            4.1 Impact Analysis                

                        4.1.1 Drivers  

                        4.1.2 Restraints          

                        4.1.3 Opportunities   

            4.2 Regulatory Environment              

            4.3 Technology Timeline & Recent Trends                

5. Competitor Benchmarking Analysis                                  

            5.1 Key Player Benchmarking            

                        5.1.1 Market share analysis   

                        5.1.2 Products/Service          

                        5.1.3 Regional Presence        

            5.2 Mergers & Acquisition Landscape                       

            5.3 Joint Ventures & Collaborations              

6. Market Segmentation                                

            6.1 Global Oncology drugs Market, By Type            

            6.2  Lung Cancer                    

            6.3   Pancreatic Cancer                      

            6.4 Breast Cancer                  

            6.5 Prostate Cancer               

            6.6 Ovarian Cancer                

            6.7    Colorectal Cancer                      

            6.8 Gastric Cancer                  

            6.9 Kidney Cancer                  

            6.10 Brain Cancer                  

            6.11 Brain Cancer                  

            6.12 Thyroid Cancer              

                        6.12.1 Market Size Estimations & Forecasts (2021-2026)    

                        6.12.2 Y-o-Y Growth Rate Analysis    

                        6.12.3 Market Attractiveness Index  

            6.13 Global Oncology drugs Market, By Drug Class Type:                

            6.14 Chemotherapy               

            6.15  Targeted Therapy                     

            6.16   Immunotherapy (Biologic Therapy)                 

            6.17  Hormonal Therapy                    

                        6.17.1 Market Size Estimations & Forecasts (2021-2026)    

                        6.17.2 Y-o-Y Growth Rate Analysis    

                        6.17.3 Market Attractiveness Index  

            6.18 Global Oncology drugs Market, By Distribution Channel:                     

            6.19 Hospital Pharmacies                  

            6.20  Retail Pharmacies/Drug Stores             

            6.21 Others                                                                

                        6.21.1 Market Size Estimations & Forecasts (2021-2026)    

                        6.21.2 Y-o-Y Growth Rate Analysis    

                        6.21.3 Market Attractiveness Index  

            6.22 Global Oncology drugs Market, By Route of Administration:               

            6.23  Oral                   

            6.24 Parenteral                      

            6.25 Others                   

                        6.25.1 Market Size Estimations & Forecasts (2021-2026)    

                        6.25.2 Y-o-Y Growth Rate Analysis    

                        6.25.3 Market Attractiveness Index  

            6.26 Global Oncology drugs Market, By Drug Classification:            

            6.27 Branded Drugs               

            6.28 Generic Drugs                       

                        6.28.1 Market Size Estimations & Forecasts (2021-2026)    

                        6.28.2 Y-o-Y Growth Rate Analysis    

                        6.28.3 Market Attractiveness Index  

7. Geographical Landscape                            

            7.1 Global Identity Governance and Administration Market, by Region                  

            7.2 North America - Market Analysis (2021 - 2026)              

                        7.2.1 By Country        

                                    7.2.1.1 USA

                                    7.2.1.2 Canada

                        7.2.2 By Type 

                        7.2.3  By Drug Class Type:     

                        7.2.4 By Distribution Channel:           

                        7.2.5 By Route of Administration:     

                        7.2.6 By Drug Classification:  

            7.3 Europe                 

                        7.3.1 By Country        

                                    7.3.1.1 UK

                                    7.3.1.2 France

                                    7.3.1.3 Germany

                                    7.3.1.4 Spain

                                    7.3.1.5 Italy

                                    7.3.1.6 Rest of Europe

                        7.3.2 By Type 

                        7.3.3  By Drug Class Type:     

                        7.3.4 By Distribution Channel:           

                        7.3.5 By Route of Administration:     

                        7.3.6 By Drug Classification:  

            7.4 Asia Pacific                       

                        7.4.1 By Country        

                                    7.4.1.1 China

                                    7.4.1.2 India

                                    7.4.1.3 Japan

                                    7.4.1.4 South Korea

                                    7.4.1.5 South East Asia

                                    7.4.1.6 Australia & NZ

                                    7.4.1.7 Rest of Asia-Pacific

                        7.4.2 By Type 

                        7.4.3  By Drug Class Type:     

                        7.4.4 By Distribution Channel:           

                        7.4.5 By Route of Administration:     

                        7.4.6 By Drug Classification:  

            7.5 Latin America                   

                        7.5.1 By Country        

                                    7.5.1.1 Brazil

                                    7.5.1.2 Argentina

                                    7.5.1.3 Mexico

                                    7.5.1.4 Rest of Latin America

                        7.5.2 By Type 

                        7.5.3  By Drug Class Type:     

                        7.5.4 By Distribution Channel:           

                        7.5.5 By Route of Administration:     

                        7.5.6 By Drug Classification:  

            7.6 Middle East and Africa                 

                        7.6.1 By Country        

                                    7.6.1.1 Middle East

                                    7.6.1.2 Africa

                        7.6.2 By Type 

                        7.6.3  By Drug Class Type:     

                        7.6.4 By Distribution Channel:           

                        7.6.5 By Route of Administration:     

                        7.6.6 By Drug Classification:              

8. Key Player Analysis            

            8.1 Pfizer

8.1.1 Business Description    

                        8.1.2 Products/Service          

                        8.1.3 Financials          

                        8.1.4 SWOT Analysis  

                        8.1.5 Recent Developments  

8.1.6 Analyst Overview

            8.2 Johnson & Johnson

            8.3 Novartis

            8.4 Bristol-Meyers Squibb Company

            8.5 AstraZeneca PLC

            8.6 F Hoffmann-La Roche Ltd

            8.7 Merck & Co

            8.8 AbbVie Inc.

            8.9 Astellas Pharma Inc.

            8.10 Amgen Inc.

9. Market Outlook & Investment Opportunities                               

10. Appendix                           

            List of Tables              

            List of Figures             

 

  • Global, regional, and country-level analysis and forecasts of the study market; providing Insights on the major countries/regions in which this industry is blooming and also identify the areas that are still untapped. 
  • The segment-level analysis in terms of type, drug class type, distribution channel, route of administration, drug classification, and region along with market size forecasts and estimations to detect key areas of industry growth in detail.
  • Identification of key drivers, restraints, opportunities, and challenges (DROC) in the market and their impact on shifting market dynamics.
  • Study of the effect of exogenous and endogenous factors that affect the global market; which includes broadly demographic, economics, and political, among other macro-environmental factors presented in an extensive PESTLE Analysis.
  • Study the microenvironment factors that determine the overall profitability of an Industry, using Porter’s five forces analysis for analyzing the level of competition and business strategy development.
  • A comprehensive list of key market players along with their product portfolio, current strategic interests, essential financial information, legal issues, SWOT analysis, and analyst overview to study and sustain the market environment.
  • Competitive landscape analysis listing out the mergers, acquisitions, collaborations in the field along with new product launches, comparative financial studies, and recent developments in the market by the major companies
  • An executive summary, abridging the entire report in such a way that decision-making personnel can rapidly become acquainted with background information, concise analysis, and main conclusions.
  • Expertly devised analyst overview along with Investment opportunities to provide both individuals and organizations with a strong financial foothold in the market.

 

  1. Global Oncology drugs Market, By Region, From 2021 to 2026 (USD Billion)
  2. Global Oncology drugs Market, By Type, From 2021 to 2026 (USD Billion)
  3. Global Lung Cancer Market, By Region, From 2021 to 2026 (USD Billion)
  4. Global  Pancreatic Cancer Market, By Region, From 2021 to 2026 (USD Billion)
  5. Global  Breast Cancer Market, By Region, From 2021 to 2026 (USD Billion)
  6. Global   Prostate Cancer Market, By Region, From 2021 to 2026 (USD Billion)
  7. Global Ovarian Cancer Market, By Region, From 2021 to 2026 (USD Billion)
  8. Global   Colorectal Cancer Market, By Region, From 2021 to 2026 (USD Billion)
  9. Global Gastric Cancer Market, By Region, From 2021 to 2026 (USD Billion)
  10. Global Kidney Cancer Market, By Region, From 2021 to 2026 (USD Billion)
  11. Global  Brain Cancer Market, By Region, From 2021 to 2026 (USD Billion)
  12. Global   Thyroid Cancer Market, By Region, From 2021 to 2026 (USD Billion)
  13. Global Oncology drugs Market, By Drug Class Type, From 2021 to 2026 (USD Billion)
  14. Global Chemotherapy Market, By Region, From 2021 to 2026 (USD Billion)
  15. Global  Targeted Therapy Market, By Region, From 2021 to 2026 (USD Billion)
  16. Global  Immunotherapy (Biologic Therapy) Market, By Region, From 2021 to 2026 (USD Billion)
  17. Global  Hormonal Therapy Market, By Region, From 2021 to 2026 (USD Billion)
  18. Global Oncology drugs Market, By Distribution Channel, From 2021 to 2026 (USD Billion)
  19. Global   Hospital Pharmacies Market, By Region, From 2021 to 2026 (USD Billion)
  20. Global    Retail Pharmacies/Drug Stores Market, By Region, From 2021 to 2026 (USD Billion)
  21. Global  Others Market, By Region, From 2021 to 2026 (USD Billion)
  22. Global Oncology drugs Market, By Route of Administration, From 2021 to 2026 (USD Billion)
  23. Global  Oral Market, By Region, From 2021 to 2026 (USD Billion)
  24. Global Parenteral Market, By Region, From 2021 to 2026 (USD Billion)
  25. Global Others Market, By Region, From 2021 to 2026 (USD Billion)
  26. Global Oncology drugs Market, By Drug Classification, From 2021 to 2026 (USD Billion)
  27. Global  Branded Drugs Market, By Region, From 2021 to 2026 (USD Billion)
  28. Global   Generic Drugs Market, By Region, From 2021 to 2026 (USD Billion)
  29. North America Global Oncology drugs Market, By Type, From 2021 to 2026 (USD Billion)
  30. North America Lung Cancer Market, By Region, From 2021 to 2026 (USD Billion)
  31. North America  Pancreatic Cancer Market, By Region, From 2021 to 2026 (USD Billion)
  32. North America  Breast Cancer Market, By Region, From 2021 to 2026 (USD Billion)
  33. North America   Prostate Cancer Market, By Region, From 2021 to 2026 (USD Billion)
  34. North America Ovarian Cancer Market, By Region, From 2021 to 2026 (USD Billion)
  35. North America   Colorectal Cancer Market, By Region, From 2021 to 2026 (USD Billion)
  36. North America Gastric Cancer Market, By Region, From 2021 to 2026 (USD Billion)
  37. North America Kidney Cancer Market, By Region, From 2021 to 2026 (USD Billion)
  38. North America  Brain Cancer Market, By Region, From 2021 to 2026 (USD Billion)
  39. North America   Thyroid Cancer Market, By Region, From 2021 to 2026 (USD Billion)
  40. North America Global Oncology drugs Market, By Drug Class Type, From 2021 to 2026 (USD Billion)
  41. North America Chemotherapy Market, By Region, From 2021 to 2026 (USD Billion)
  42. North America  Targeted Therapy Market, By Region, From 2021 to 2026 (USD Billion)
  43. North America  Immunotherapy (Biologic Therapy) Market, By Region, From 2021 to 2026 (USD Billion)
  44. North America  Hormonal Therapy Market, By Region, From 2021 to 2026 (USD Billion)
  45. North America Global Oncology drugs Market, By Distribution Channel, From 2021 to 2026 (USD Billion)
  46. North America   Hospital Pharmacies Market, By Region, From 2021 to 2026 (USD Billion)
  47. North America    Retail Pharmacies/Drug Stores Market, By Region, From 2021 to 2026 (USD Billion)
  48. North America  Others Market, By Region, From 2021 to 2026 (USD Billion)
  49. North America Global Oncology drugs Market, By Route of Administration, From 2021 to 2026 (USD Billion)
  50. North America  Oral Market, By Region, From 2021 to 2026 (USD Billion)
  51. North America Parenteral Market, By Region, From 2021 to 2026 (USD Billion)
  52. North America Others Market, By Region, From 2021 to 2026 (USD Billion)
  53. North America Global Oncology drugs Market, By Drug Classification, From 2021 to 2026 (USD Billion)
  54. North America  Branded Drugs Market, By Region, From 2021 to 2026 (USD Billion)
  55. North America   Generic Drugs Market, By Region, From 2021 to 2026 (USD Billion)
  56. United States Global Oncology drugs Market, By Type, From 2021 to 2026 (USD Billion)
  57. United States Global Oncology drugs Market, By Drug Class Type, From 2021 to 2026 (USD Billion)
  58. United States Global Oncology drugs Market, By Distribution Channel, From 2021 to 2026 (USD Billion)
  59. United States Global Oncology drugs Market, By Route of Administration, From 2021 to 2026 (USD Billion)
  60. United States Global Oncology drugs Market, By Drug Classification, From 2021 to 2026 (USD Billion)
  61. Canada Global Oncology drugs Market, By Type, From 2021 to 2026 (USD Billion)
  62. Canada Global Oncology drugs Market, By Drug Class Type, From 2021 to 2026 (USD Billion)
  63. Canada Global Oncology drugs Market, By Distribution Channel, From 2021 to 2026 (USD Billion)
  64. Canada Global Oncology drugs Market, By Route of Administration, From 2021 to 2026 (USD Billion)
  65. Canada Global Oncology drugs Market, By Drug Classification, From 2021 to 2026 (USD Billion)
  66. Europe Global Oncology drugs Market, By Type, From 2021 to 2026 (USD Billion)
  67. Europe Lung Cancer Market, By Region, From 2021 to 2026 (USD Billion)
  68. Europe  Pancreatic Cancer Market, By Region, From 2021 to 2026 (USD Billion)
  69. Europe  Breast Cancer Market, By Region, From 2021 to 2026 (USD Billion)
  70. Europe   Prostate Cancer Market, By Region, From 2021 to 2026 (USD Billion)
  71. Europe Ovarian Cancer Market, By Region, From 2021 to 2026 (USD Billion)
  72. Europe   Colorectal Cancer Market, By Region, From 2021 to 2026 (USD Billion)
  73. Europe Gastric Cancer Market, By Region, From 2021 to 2026 (USD Billion)
  74. Europe Kidney Cancer Market, By Region, From 2021 to 2026 (USD Billion)
  75. Europe  Brain Cancer Market, By Region, From 2021 to 2026 (USD Billion)
  76. Europe   Thyroid Cancer Market, By Region, From 2021 to 2026 (USD Billion)
  77. Europe Global Oncology drugs Market, By Drug Class Type, From 2021 to 2026 (USD Billion)
  78. Europe Chemotherapy Market, By Region, From 2021 to 2026 (USD Billion)
  79. Europe  Targeted Therapy Market, By Region, From 2021 to 2026 (USD Billion)
  80. Europe  Immunotherapy (Biologic Therapy) Market, By Region, From 2021 to 2026 (USD Billion)
  81. Europe  Hormonal Therapy Market, By Region, From 2021 to 2026 (USD Billion)
  82. Europe Global Oncology drugs Market, By Distribution Channel, From 2021 to 2026 (USD Billion)
  83. Europe   Hospital Pharmacies Market, By Region, From 2021 to 2026 (USD Billion)
  84. Europe    Retail Pharmacies/Drug Stores Market, By Region, From 2021 to 2026 (USD Billion)
  85. Europe  Others Market, By Region, From 2021 to 2026 (USD Billion)
  86. Europe Global Oncology drugs Market, By Route of Administration, From 2021 to 2026 (USD Billion)
  87. Europe  Oral Market, By Region, From 2021 to 2026 (USD Billion)
  88. Europe Parenteral Market, By Region, From 2021 to 2026 (USD Billion)
  89. Europe Others Market, By Region, From 2021 to 2026 (USD Billion)
  90. Europe Global Oncology drugs Market, By Drug Classification, From 2021 to 2026 (USD Billion)
  91. Europe  Branded Drugs Market, By Region, From 2021 to 2026 (USD Billion)
  92. Europe   Generic Drugs Market, By Region, From 2021 to 2026 (USD Billion)
  93. U.K. Global Oncology drugs Market, By Type, From 2021 to 2026 (USD Billion)
  94. U.K. Global Oncology drugs Market, By Drug Class Type, From 2021 to 2026 (USD Billion)
  95. U.K. Global Oncology drugs Market, By Distribution Channel, From 2021 to 2026 (USD Billion)
  96. U.K. Global Oncology drugs Market, By Route of Administration, From 2021 to 2026 (USD Billion)
  97. U.K. Global Oncology drugs Market, By Drug Classification, From 2021 to 2026 (USD Billion)
  98. Germany Global Oncology drugs Market, By Type, From 2021 to 2026 (USD Billion)
  99. Germany Global Oncology drugs Market, By Drug Class Type, From 2021 to 2026 (USD Billion)
  100. Germany Global Oncology drugs Market, By Distribution Channel, From 2021 to 2026 (USD Billion)
  101. Germany Global Oncology drugs Market, By Route of Administration, From 2021 to 2026 (USD Billion)
  102. Germany Global Oncology drugs Market, By Drug Classification, From 2021 to 2026 (USD Billion)
  103. France Global Oncology drugs Market, By Type, From 2021 to 2026 (USD Billion)
  104. France Global Oncology drugs Market, By Drug Class Type, From 2021 to 2026 (USD Billion)
  105. France Global Oncology drugs Market, By Distribution Channel, From 2021 to 2026 (USD Billion)
  106. France Global Oncology drugs Market, By Route of Administration, From 2021 to 2026 (USD Billion)
  107. France Global Oncology drugs Market, By Drug Classification, From 2021 to 2026 (USD Billion)
  108. Italy Global Oncology drugs Market, By Type, From 2021 to 2026 (USD Billion)
  109. Italy Global Oncology drugs Market, By Drug Class Type, From 2021 to 2026 (USD Billion)
  110. Italy Global Oncology drugs Market, By Distribution Channel, From 2021 to 2026 (USD Billion)
  111. Italy Global Oncology drugs Market, By Route of Administration, From 2021 to 2026 (USD Billion)
  112. Italy Global Oncology drugs Market, By Drug Classification, From 2021 to 2026 (USD Billion)
  113. Spain Global Oncology drugs Market, By Type, From 2021 to 2026 (USD Billion)
  114. Spain Global Oncology drugs Market, By Drug Class Type, From 2021 to 2026 (USD Billion)
  115. Spain Global Oncology drugs Market, By Distribution Channel, From 2021 to 2026 (USD Billion)
  116. Spain Global Oncology drugs Market, By Route of Administration, From 2021 to 2026 (USD Billion)
  117. Spain Global Oncology drugs Market, By Drug Classification, From 2021 to 2026 (USD Billion)
  118. Asia Pacific Global Oncology drugs Market, By Type, From 2021 to 2026 (USD Billion)
  119. Asia Pacific Lung Cancer Market, By Region, From 2021 to 2026 (USD Billion)
  120. Asia Pacific  Pancreatic Cancer Market, By Region, From 2021 to 2026 (USD Billion)
  121. Asia Pacific  Breast Cancer Market, By Region, From 2021 to 2026 (USD Billion)
  122. Asia Pacific   Prostate Cancer Market, By Region, From 2021 to 2026 (USD Billion)
  123. Asia Pacific Ovarian Cancer Market, By Region, From 2021 to 2026 (USD Billion)
  124. Asia Pacific   Colorectal Cancer Market, By Region, From 2021 to 2026 (USD Billion)
  125. Asia Pacific Gastric Cancer Market, By Region, From 2021 to 2026 (USD Billion)
  126. Asia Pacific Kidney Cancer Market, By Region, From 2021 to 2026 (USD Billion)
  127. Asia Pacific  Brain Cancer Market, By Region, From 2021 to 2026 (USD Billion)
  128. Asia Pacific   Thyroid Cancer Market, By Region, From 2021 to 2026 (USD Billion)
  129. Asia Pacific Global Oncology drugs Market, By Drug Class Type, From 2021 to 2026 (USD Billion)
  130. Asia Pacific Chemotherapy Market, By Region, From 2021 to 2026 (USD Billion)
  131. Asia Pacific  Targeted Therapy Market, By Region, From 2021 to 2026 (USD Billion)
  132. Asia Pacific  Immunotherapy (Biologic Therapy) Market, By Region, From 2021 to 2026 (USD Billion)
  133. Asia Pacific  Hormonal Therapy Market, By Region, From 2021 to 2026 (USD Billion)
  134. Asia Pacific Global Oncology drugs Market, By Distribution Channel, From 2021 to 2026 (USD Billion)
  135. Asia Pacific   Hospital Pharmacies Market, By Region, From 2021 to 2026 (USD Billion)
  136. Asia Pacific    Retail Pharmacies/Drug Stores Market, By Region, From 2021 to 2026 (USD Billion)
  137. Asia Pacific  Others Market, By Region, From 2021 to 2026 (USD Billion)
  138. Asia Pacific Global Oncology drugs Market, By Route of Administration, From 2021 to 2026 (USD Billion)
  139. Asia Pacific  Oral Market, By Region, From 2021 to 2026 (USD Billion)
  140. Asia Pacific Parenteral Market, By Region, From 2021 to 2026 (USD Billion)
  141. Asia Pacific Others Market, By Region, From 2021 to 2026 (USD Billion)
  142. Asia Pacific Global Oncology drugs Market, By Drug Classification, From 2021 to 2026 (USD Billion)
  143. Asia Pacific  Branded Drugs Market, By Region, From 2021 to 2026 (USD Billion)
  144. Asia Pacific   Generic Drugs Market, By Region, From 2021 to 2026 (USD Billion)
  145. Japan Global Oncology drugs Market, By Type, From 2021 to 2026 (USD Billion)
  146. Japan Global Oncology drugs Market, By Drug Class Type, From 2021 to 2026 (USD Billion)
  147. Japan Global Oncology drugs Market, By Distribution Channel, From 2021 to 2026 (USD Billion)
  148. Japan Global Oncology drugs Market, By Route of Administration, From 2021 to 2026 (USD Billion)
  149. Japan Global Oncology drugs Market, By Drug Classification, From 2021 to 2026 (USD Billion)
  150. China Global Oncology drugs Market, By Type, From 2021 to 2026 (USD Billion)
  151. China Global Oncology drugs Market, By Drug Class Type, From 2021 to 2026 (USD Billion)
  152. China Global Oncology drugs Market, By Distribution Channel, From 2021 to 2026 (USD Billion)
  153. China Global Oncology drugs Market, By Route of Administration, From 2021 to 2026 (USD Billion)
  154. China Global Oncology drugs Market, By Drug Classification, From 2021 to 2026 (USD Billion)
  155. India Global Oncology drugs Market, By Type, From 2021 to 2026 (USD Billion)
  156. India Global Oncology drugs Market, By Drug Class Type, From 2021 to 2026 (USD Billion)
  157. India Global Oncology drugs Market, By Distribution Channel, From 2021 to 2026 (USD Billion)
  158. India Global Oncology drugs Market, By Route of Administration, From 2021 to 2026 (USD Billion)
  159. India Global Oncology drugs Market, By Drug Classification, From 2021 to 2026 (USD Billion)
  160. Australia Global Oncology drugs Market, By Type, From 2021 to 2026 (USD Billion)
  161. Australia Global Oncology drugs Market, By Drug Class Type, From 2021 to 2026 (USD Billion)
  162. Australia Global Oncology drugs Market, By Distribution Channel, From 2021 to 2026 (USD Billion)
  163. Australia Global Oncology drugs Market, By Route of Administration, From 2021 to 2026 (USD Billion)
  164. Australia Global Oncology drugs Market, By Drug Classification, From 2021 to 2026 (USD Billion)
  165. South Korea Global Oncology drugs Market, By Type, From 2021 to 2026 (USD Billion)
  166. South Korea Global Oncology drugs Market, By Drug Class Type, From 2021 to 2026 (USD Billion)
  167. South Korea Global Oncology drugs Market, By Distribution Channel, From 2021 to 2026 (USD Billion)
  168. South Korea Global Oncology drugs Market, By Route of Administration, From 2021 to 2026 (USD Billion)
  169. South Korea Global Oncology drugs Market, By Drug Classification, From 2021 to 2026 (USD Billion)
  170. Latin America  Oral Market, By Region, From 2021 to 2026 (USD Billion)
  171. Latin America Parenteral Market, By Region, From 2021 to 2026 (USD Billion)
  172. Latin America Others Market, By Region, From 2021 to 2026 (USD Billion)
  173. Latin America Global Oncology drugs Market, By Drug Classification, From 2021 to 2026 (USD Billion)
  174. Latin America  Branded Drugs Market, By Region, From 2021 to 2026 (USD Billion)
  175. Latin America   Generic Drugs Market, By Region, From 2021 to 2026 (USD Billion)
  176. Brazil Global Oncology drugs Market, By Type, From 2021 to 2026 (USD Billion)
  177. Brazil Global Oncology drugs Market, By Drug Class Type, From 2021 to 2026 (USD Billion)
  178. Brazil Global Oncology drugs Market, By Distribution Channel, From 2021 to 2026 (USD Billion)
  179. Brazil Global Oncology drugs Market, By Route of Administration, From 2021 to 2026 (USD Billion)
  180. Brazil Global Oncology drugs Market, By Drug Classification, From 2021 to 2026 (USD Billion)
  181. Argentina Global Oncology drugs Market, By Type, From 2021 to 2026 (USD Billion)
  182. Argentina Global Oncology drugs Market, By Drug Class Type, From 2021 to 2026 (USD Billion)
  183. Argentina Global Oncology drugs Market, By Distribution Channel, From 2021 to 2026 (USD Billion)
  184. Argentina Global Oncology drugs Market, By Route of Administration, From 2021 to 2026 (USD Billion)
  185. Argentina Global Oncology drugs Market, By Drug Classification, From 2021 to 2026 (USD Billion)
  186. Mexico Global Oncology drugs Market, By Type, From 2021 to 2026 (USD Billion)
  187. Mexico Global Oncology drugs Market, By Drug Class Type, From 2021 to 2026 (USD Billion)
  188. Mexico Global Oncology drugs Market, By Distribution Channel, From 2021 to 2026 (USD Billion)
  189. Mexico Global Oncology drugs Market, By Route of Administration, From 2021 to 2026 (USD Billion)
  190. Mexico Global Oncology drugs Market, By Drug Classification, From 2021 to 2026 (USD Billion)
  191. Rest of Latin America Global Oncology drugs Market, By Type, From 2021 to 2026 (USD Billion)
  192. Rest of Latin America Global Oncology drugs Market, By Drug Class Type, From 2021 to 2026 (USD Billion)
  193. Rest of Latin America Global Oncology drugs Market, By Distribution Channel, From 2021 to 2026 (USD Billion)
  194. Rest of Latin America Global Oncology drugs Market, By Route of Administration, From 2021 to 2026 (USD Billion)
  195. Rest of Latin America Global Oncology drugs Market, By Drug Classification, From 2021 to 2026 (USD Billion)
  196. Middle East and Africa Global Oncology drugs Market, By Type, From 2021 to 2026 (USD Billion)
  197. Middle East and Africa Lung Cancer Market, By Region, From 2021 to 2026 (USD Billion)
  198. Middle East and Africa  Pancreatic Cancer Market, By Region, From 2021 to 2026 (USD Billion)
  199. Middle East and Africa  Breast Cancer Market, By Region, From 2021 to 2026 (USD Billion)
  200. Middle East and Africa   Prostate Cancer Market, By Region, From 2021 to 2026 (USD Billion)
  201. Middle East and Africa Ovarian Cancer Market, By Region, From 2021 to 2026 (USD Billion)
  202. Middle East and Africa   Colorectal Cancer Market, By Region, From 2021 to 2026 (USD Billion)
  203. Middle East and Africa Gastric Cancer Market, By Region, From 2021 to 2026 (USD Billion)
  204. Middle East and Africa Kidney Cancer Market, By Region, From 2021 to 2026 (USD Billion)
  205. Middle East and Africa  Brain Cancer Market, By Region, From 2021 to 2026 (USD Billion)
  206. Middle East and Africa   Thyroid Cancer Market, By Region, From 2021 to 2026 (USD Billion)
  207. Middle East and Africa Global Oncology drugs Market, By Drug Class Type, From 2021 to 2026 (USD Billion)
  208. Middle East and Africa Chemotherapy Market, By Region, From 2021 to 2026 (USD Billion)
  209. Middle East and Africa  Targeted Therapy Market, By Region, From 2021 to 2026 (USD Billion)
  210. Middle East and Africa  Immunotherapy (Biologic Therapy) Market, By Region, From 2021 to 2026 (USD Billion)
  211. Middle East and Africa  Hormonal Therapy Market, By Region, From 2021 to 2026 (USD Billion)
  212. Middle East and Africa Global Oncology drugs Market, By Distribution Channel, From 2021 to 2026 (USD Billion)
  213. Middle East and Africa   Hospital Pharmacies Market, By Region, From 2021 to 2026 (USD Billion)
  214. Middle East and Africa    Retail Pharmacies/Drug Stores Market, By Region, From 2021 to 2026 (USD Billion)
  215. Middle East and Africa  Others Market, By Region, From 2021 to 2026 (USD Billion)
  216. Middle East and Africa Global Oncology drugs Market, By Route of Administration, From 2021 to 2026 (USD Billion)
  217. Middle East and Africa  Oral Market, By Region, From 2021 to 2026 (USD Billion)
  218. Middle East and Africa Parenteral Market, By Region, From 2021 to 2026 (USD Billion)
  219. Middle East and Africa Others Market, By Region, From 2021 to 2026 (USD Billion)
  220. Middle East and Africa Global Oncology drugs Market, By Drug Classification, From 2021 to 2026 (USD Billion)
  221. Middle East and Africa  Branded Drugs Market, By Region, From 2021 to 2026 (USD Billion)
  222. Middle East and Africa   Generic Drugs Market, By Region, From 2021 to 2026 (USD Billion)
  223. Middle East Global Oncology drugs Market, By Type, From 2021 to 2026 (USD Billion)
  224. Middle East Global Oncology drugs Market, By Drug Class Type, From 2021 to 2026 (USD Billion)
  225. Middle East Global Oncology drugs Market, By Distribution Channel, From 2021 to 2026 (USD Billion)
  226. Middle East Global Oncology drugs Market, By Route of Administration, From 2021 to 2026 (USD Billion)
  227. Middle East Global Oncology drugs Market, By Drug Classification, From 2021 to 2026 (USD Billion)
  228. Africa Global Oncology drugs Market, By Type, From 2021 to 2026 (USD Billion)
  229. Africa Global Oncology drugs Market, By Drug Class Type, From 2021 to 2026 (USD Billion)
  230. Africa Global Oncology drugs Market, By Distribution Channel, From 2021 to 2026 (USD Billion)
  231. Africa Global Oncology drugs Market, By Route of Administration, From 2021 to 2026 (USD Billion)
  232. Africa Global Oncology drugs Market, By Drug Classification, From 2021 to 2026 (USD Billion)

Please wait. . . . Your request is being processed

Related Reports

LICENCE TYPE

$ 1234 4250

Clients
clients
clients
clients
clients
clients
clients
Click for Request Sample